Quality of life and patients' expectations in soft tissue sarcoma

Future Oncology
Robin L Jones, Axel Le Cesne

Abstract

Assessment of health-related quality of life (HRQoL) is essential for holistic care. Greater efforts are required to incorporate HRQoL measures into clinical trials and daily practice. Considerable HRQoL data are available for localized soft tissue sarcomas (STS), particularly in the orthopedic setting. In future, HRQoL is expected to become increasingly important in the evaluation of palliative therapy in advanced STS. A patient-centric approach is advocated for STS management. Greater awareness of STS by nonspecialist clinicians, and timely referral to specialized sarcoma reference centers, is crucial for patient welfare. The patient is central to shared decision-making during consultations and during case review in tumor boards. The management approach to STS should be collaborative, involving a multidisciplinary team, multiple centers and patient advocacy groups.

References

Jan 1, 1987·British Journal of Clinical Pharmacology·W F Lubbe
Oct 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A M DavisR S Bell
Oct 12, 1999·Seminars in Radiation Oncology·A M Davis
Apr 19, 2002·The Oncologist·Andrew Bottomley
Nov 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M DavisB Zee
Jun 11, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Aileen M DavisUNKNOWN NCI Canada Clinical Trial Group Randomized Trial
Feb 13, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lonnie K ZeltzerKirsten K Ness
Apr 29, 2011·European Journal of Radiology·Johan L Bloem, Inge I Reidsma
Sep 8, 2012·The Lancet Oncology·Penella J WollUNKNOWN EORTC Soft Tissue and Bone Sarcoma Group and the NCIC Clinical Trials Group Sarcoma Disease Site Committee
Apr 29, 2014·Sarcoma·Kenneth R GundleDarin J Davidson
Sep 12, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·UNKNOWN ESMO/European Sarcoma Network Working Group
Sep 12, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·UNKNOWN ESMO/European Sarcoma Network Working Group
Oct 9, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Le CesneW T A Van Der Graaf
Nov 8, 2014·Expert Review of Anticancer Therapy·Kenneth R GundleDarin J Davidson
Mar 3, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Axel Le CesneUNKNOWN French Sarcoma Group
Jul 15, 2015·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·R NandraR Grimer
Sep 16, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George D DemetriShreyaskumar R Patel
Sep 14, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher W RyanPatrick Schöffski
Oct 17, 2016·Journal of Pain and Symptom Management·Markus K SchulerFrank Kroschinsky
Jan 4, 2017·Journal of Pain and Symptom Management·Nicholas GoughIan Judson
Apr 1, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paolo G CasaliUNKNOWN European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, Italian Sarcoma Group, and Au

❮ Previous
Next ❯

Citations

May 1, 2020·Expert Review of Anticancer Therapy·Javier Martín-BrotoSilvia Stacchiotti
Aug 9, 2020·Health and Quality of Life Outcomes·Hui Jun LimMelissa Ching Ching Teo

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02204111

Software Mentioned

NetSarc
CONTICANET
SPAEN

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
I Ray-CoquardJ Y Blay
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Ángel Montero Luis
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine
Ron D HaysMarie Cowan
Current Topics in Pathology. Ergebnisse Der Pathologie
J Treuner, M Morgan
© 2022 Meta ULC. All rights reserved